How Cleo Diagnostics Is Unlocking a $2 Million Patient Market in the U.S.

middle.news 8:40am on Thursday 29th of January, 2026 AEDT • Healthcare Read Story

How Cleo Diagnostics Is Unlocking a $2 Million Patient Market in the U.S.

8:40am on Thursday 29th of January, 2026 AEDT Key Points Appointment of first U.S. Key Opinion Leader to drive clinical advocacy Total Addressable Market expanded to ~2 million women pre-surgery annually in the U.S. Pivotal U.S. clinical trial recruitment nearing 500-subject target Completion of Stage 1 MDSAP audit advancing FDA submission readiness Read Story

middle. Tap to Read Tap the card to read the full analysis about CLEO DIAGNOSTICS (ASX:COV) OPEN ARTICLE